It was excellent as it was early in Ph1 clinical trial, I'm expecting more than just another CR and increase in RR toward the end of Ph1 clinical trial. If it remain the same then it will be inline with expectation.
IMU Price at posting:
4.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)